Legato Capital Management LLC Takes $691,000 Position in Chemed Corporation $CHE

Legato Capital Management LLC purchased a new stake in Chemed Corporation (NYSE:CHE) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,615 shares of the company’s stock, valued at approximately $691,000.

Several other large investors have also modified their holdings of the business. Wilian Securities LLC bought a new stake in shares of Chemed in the 4th quarter valued at about $592,000. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed in the 4th quarter valued at about $27,000. Global Retirement Partners LLC raised its holdings in shares of Chemed by 200.0% in the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares in the last quarter. IFP Advisors Inc raised its holdings in shares of Chemed by 91.8% in the 4th quarter. IFP Advisors Inc now owns 1,671 shares of the company’s stock valued at $715,000 after purchasing an additional 800 shares in the last quarter. Finally, Covestor Ltd raised its holdings in shares of Chemed by 44.8% in the 4th quarter. Covestor Ltd now owns 375 shares of the company’s stock valued at $160,000 after purchasing an additional 116 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $438.11 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $581.20. The company has a market cap of $5.81 billion, a PE ratio of 23.88, a P/E/G ratio of 1.65 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The business has a 50-day simple moving average of $401.79 and a two-hundred day simple moving average of $424.94.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. The firm had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities analysts expect that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 13.08%.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 3.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on CHE shares. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Saturday. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Oppenheimer decreased their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada upped their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.